GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » E10

Godavari Drugs (BOM:530317) E10 : ₹4.58 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Godavari Drugs's adjusted earnings per share data for the three months ended in Dec. 2023 was ₹1.620. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹4.58 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Godavari Drugs's average E10 Growth Rate was 15.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-06), Godavari Drugs's current stock price is ₹92.47. Godavari Drugs's E10 for the quarter that ended in Dec. 2023 was ₹4.58. Godavari Drugs's Shiller PE Ratio of today is 20.19.

During the past 13 years, the highest Shiller PE Ratio of Godavari Drugs was 28.39. The lowest was 15.53. And the median was 20.37.


Godavari Drugs E10 Historical Data

The historical data trend for Godavari Drugs's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Godavari Drugs E10 Chart

Godavari Drugs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 2.51 3.56 4.17

Godavari Drugs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.97 4.17 4.32 4.41 4.58

Competitive Comparison of Godavari Drugs's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Godavari Drugs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Godavari Drugs's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Godavari Drugs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Godavari Drugs's Shiller PE Ratio falls into.



Godavari Drugs E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Godavari Drugs's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.62/152.9243*152.9243
=1.620

Current CPI (Dec. 2023) = 152.9243.

Godavari Drugs Quarterly Data

per share eps CPI Adj_EPS
201403 1.186 91.425 1.984
201406 0.550 94.103 0.894
201409 1.850 96.780 2.923
201412 1.370 96.780 2.165
201503 1.070 97.163 1.684
201506 0.770 99.841 1.179
201509 0.380 101.753 0.571
201512 0.350 102.901 0.520
201603 0.290 102.518 0.433
201606 0.580 105.961 0.837
201609 0.530 105.961 0.765
201612 0.500 105.196 0.727
201703 0.750 105.196 1.090
201706 0.120 107.109 0.171
201709 0.100 109.021 0.140
201712 0.440 109.404 0.615
201803 0.450 109.786 0.627
201806 0.230 111.317 0.316
201809 0.270 115.142 0.359
201812 0.360 115.142 0.478
201903 0.480 118.202 0.621
201906 0.570 120.880 0.721
201909 0.360 123.175 0.447
201912 0.720 126.235 0.872
202003 1.010 124.705 1.239
202006 1.130 127.000 1.361
202009 1.310 130.118 1.540
202012 1.330 130.889 1.554
202103 1.710 131.771 1.985
202106 1.890 134.084 2.156
202109 1.620 135.847 1.824
202112 1.770 138.161 1.959
202203 1.690 138.822 1.862
202206 1.220 142.347 1.311
202209 1.150 144.661 1.216
202212 0.890 145.763 0.934
202303 1.770 146.865 1.843
202306 1.080 150.280 1.099
202309 1.140 151.492 1.151
202312 1.620 152.924 1.620

Add all the adjusted EPS together and divide 10 will get our e10.


Godavari Drugs  (BOM:530317) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Godavari Drugs's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=92.47/4.58
=20.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Godavari Drugs was 28.39. The lowest was 15.53. And the median was 20.37.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Godavari Drugs E10 Related Terms

Thank you for viewing the detailed overview of Godavari Drugs's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Godavari Drugs (BOM:530317) Business Description

Traded in Other Exchanges
N/A
Address
Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003
Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines